Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type
Clinical Cancer Research, 06/15/2012
Ito Y et al. – The findings suggest that whole blood is more sensitive for clinical use than plasma. The Epstein–Barr virus (EBV)–DNA amount in whole blood was useful for predicting tumor response, toxicity and prognosis after SMILE chemotherapy for Extranodal NK/T–cell lymphoma, nasal type (ENKL).